Affimed (AFMD) Revenue & Revenue Breakdown
Affimed Revenue Highlights
Latest Revenue (Y)
$8.28M
Latest Revenue (Q)
$155.00K
Main Segment (Y)
Collaboration
Main Geography (Y)
USA
Affimed Revenue by Period
Affimed Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -79.99% |
2022-12-31 | - | 2.45% |
2021-12-31 | - | 42.33% |
2020-12-31 | - | 32.58% |
2019-12-31 | - | -9.88% |
2018-12-31 | - | 1080.85% |
2017-12-31 | - | -68.17% |
2016-12-31 | - | -16.50% |
2015-12-31 | - | 123.60% |
2014-12-31 | - | -33.52% |
2013-12-31 | - | 333.67% |
2012-12-31 | - | - |
Affimed Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -62.47% |
2023-12-31 | - | -78.95% |
2023-09-30 | - | 41.15% |
2023-06-30 | - | -69.18% |
2023-03-31 | - | -59.58% |
2022-12-31 | - | -25.05% |
2022-09-30 | - | 103.92% |
2022-06-30 | - | -8.81% |
2022-03-31 | - | -22.56% |
2021-12-31 | - | 19.35% |
2021-09-30 | - | -10.77% |
2021-06-30 | - | -16.74% |
2021-03-31 | - | 19.63% |
2020-12-31 | - | -7.58% |
2020-09-30 | - | 259.41% |
2020-06-30 | - | -42.86% |
2020-03-31 | - | 30.76% |
2019-12-31 | - | 86.73% |
2019-09-30 | - | -47.53% |
2019-06-30 | - | -64.70% |
2019-03-31 | - | -50.09% |
2018-12-31 | - | 7333.66% |
2018-09-30 | - | 104.00% |
2018-06-30 | - | -71.80% |
2018-03-31 | - | -16.35% |
2017-12-31 | - | 36.19% |
2017-09-30 | - | -8.07% |
2017-06-30 | - | 27.32% |
2017-03-31 | - | -70.90% |
2016-12-31 | - | 46.16% |
2016-09-30 | - | -54.66% |
2016-06-30 | - | 6.87% |
2016-03-31 | - | 16.70% |
2015-12-31 | - | 43.64% |
2015-09-30 | - | -47.74% |
2015-06-30 | - | -12.92% |
2015-03-31 | - | 3033.33% |
2014-12-31 | - | -95.72% |
2014-09-30 | - | 175.40% |
2014-06-30 | - | -4.85% |
2014-03-31 | - | -84.39% |
2013-12-31 | - | 2321.47% |
2013-09-30 | - | -4.98% |
2013-06-30 | - | 187.14% |
2013-03-31 | - | - |
Affimed Revenue Breakdown
Affimed Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Collaboration | - | - | - | - | - |
Service | - | - | - | - | - |
Services | - | - | - | - | - |
Collaboration Service | - | - | - | - | - |
Latest
Quarterly Revenue by Product
Product/Service | Dec 23 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
---|---|---|---|---|---|---|
Collaboration | - | - | - | - | - | - |
Service | - | - | - | - | - | - |
Services | - | - | - | - | - | - |
Collaboration Service | - | - | - | - | - | - |
Latest
Affimed Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
USA | - | - | - | - | - |
Germany | - | - | - | - | - |
Europe | - | - | - | - | - |
U | - | - | - | - | - |
D | - | - | - | - | - |
Latest
Quarterly Revenue by Country
Country | Dec 23 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
---|---|---|---|---|---|---|
USA | - | - | - | - | - | - |
Germany | - | - | - | - | - | - |
U | - | - | - | - | - | - |
D | - | - | - | - | - | - |
Europe | - | - | - | - | - | - |
Latest
Affimed Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AGEN | Agenus | - | - |
ADCT | ADC Therapeutics SA | - | - |
ADAP | Adaptimmune Therapeutics | - | - |
PIRS | Pieris Pharmaceuticals | - | - |
MREO | Mereo BioPharma Group | - | - |
AFMD | Affimed | - | - |
CRVS | Corvus Pharmaceuticals | - | - |
APTO | Aptose Biosciences | - | - |
XFOR | X4 Pharmaceuticals | - | - |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
LPTX | Leap Therapeutics | - | - |
ELEV | Elevation Oncology | - | - |
TERN | Terns Pharmaceuticals | - | - |
HEPA | Hepion Pharmaceuticals | - | - |
EFTR | eFFECTOR Therapeutics | - | - |